Status:
COMPLETED
Acute Effects of Fitness Drink Formulas on Energy Expenditure and Fat Metabolism
Lead Sponsor:
University of Central Florida
Collaborating Sponsors:
Celsius Holdings, Inc.
Conditions:
Caffeine
Diet, Healthy
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
The purpose of this investigation was to examine the acute effects of consuming two different fitness drink formulas on the physiological response at rest and to exercise in healthy men and women.
Detailed Description
Thermogenic fitness drinks containing \~200mg of caffeine have been reported to accelerate the metabolism, increase energy, and consequently promote increased fat oxidation. However, determination of ...
Eligibility Criteria
Inclusion
- Young adult men and women between the ages of 18 and 35 years old.
- Participant is deemed by the investigator to be healthy and free of any physical limitations determined by physical activity readiness questionnaire (PAR-Q+) and medical and activity history questionnaire (MHQ).
- Participants will be required to be recreationally-active (defined according to American College of Sports Medicine standards of at least 150 minutes exercise per week and verified by information provided in the MHQ).
- Participant is willing to abstain from dietary supplementation throughout the duration of the study as indicated in the Informed Consent.
- Participant understands the study procedures and signs forms providing informed consent to participate in the study.
Exclusion
- Inability to perform physical exercise, as determined by the PAR-Q+.
- Any "Yes" response in the PAR-Q+.
- History of hypertension, metabolic, hepatorenal, musculoskeletal, autoimmune or neurological disease, as determined by the MHQ.
- Regular consumption of greater than 250 mg per day of caffeine
- Currently taking thyroid, antihyperlipidemic, hypoglycemic, anti-hypertensive or androgenic medications.
- Taking any other nutritional supplement or performance-enhancing drug (determined from MHQ) that may interfere with the outcome variables of the study.
- Pregnancy (determined from MHQ).
Key Trial Info
Start Date :
March 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 28 2018
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04455009
Start Date
March 8 2018
End Date
November 28 2018
Last Update
July 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kinesiology Laboratories
Orlando, Florida, United States, 32816